Summit Therapeutics (SMMT)
(Real Time Quote from BATS)
$12.61 USD
-0.25 (-1.94%)
Updated Aug 30, 2024 12:00 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 16.67% |
ABR | 1.00 |
Earnings ESP
|
7.69% |
---|---|
Current Year | -0.27 |
Next Year | -0.29 |
EPS (TTM) | -0.17 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.27M | 0.20M | 15.12M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | -0.07 | -0.27 | -0.29 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.06 | -0.06 | -0.26 | -0.26 |
High Estimate | -0.06 | -0.06 | -0.26 | -0.26 |
Low Estimate | -0.07 | -0.07 | -0.28 | -0.31 |
Year ago EPS | -0.03 | -0.04 | -0.13 | -0.27 |
Year over Year Growth Est. | -133.33% | -75.00% | -107.69% | -5.56% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | -0.07 | -0.27 | -0.29 |
7 Days Ago | -0.07 | -0.07 | -0.27 | -0.29 |
30 Days Ago | -0.07 | -0.07 | -0.26 | -0.32 |
60 Days Ago | -0.07 | -0.07 | -0.26 | -0.32 |
90 Days Ago | -0.06 | -0.07 | -0.25 | -0.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.06 | -0.06 | -0.27 | -0.29 |
Zacks Consensus Estimate | -0.07 | -0.07 | -0.27 | -0.29 |
Earnings ESP | 7.69% | 7.69% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | -0.05 | -0.04 | -0.03 | NA |
Estimate | -0.06 | -0.06 | NA | NA | NA |
Difference | 0.01 | 0.01 | NA | NA | 0.01 |
Surprise | 16.67% | 16.67% | NA | NA | 16.67% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more